Earnings
Flagship will pour in $75 million into Vesalius to support its beginnings, while Rondo raised $67 million to support the development of its preclinical pipeline.
Moderna, Pfizer and BioNTech and Johnson & Johnson earned an approximate combined revenue of $31 billion in 2021, thanks to the success of their mRNA vaccines against COVID-19.
In Moderna’s fourth-quarter 2021 annual report, the company announced $7.2 billion in fourth-quarter revenues and full-year 2021 revenues of $18.5 billion.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Proceeds will be used to assemble and develop a diversified pipeline of therapies to address sight-threatening illnesses.
Prescription drug costs have continued to rise, with more than 150 drug manufacturers raising their prices in January.
The strategic collaboration centers on Remix’s REMaster platform for the discovery and development of small molecule therapies that modulate RNA processing.
Biopharma and life sciences companies from across the globe provide updates to their pipelines and businesses.
TenSixteen Bio recently came out of stealth mode with $40 million in funding to target somatic mosaicism – particularly clonal hematopoiesis of indeterminate potential (CHIP).
Kallyope focuses on the gut-brain axis, a bi-directional communication between the gastrointestinal tract and the brain.
PRESS RELEASES